Id-1 and Id-2 genes and products as therapeutic targets for treatment of breast cancer and other types of carcinoma
Patent
·
OSTI ID:1159928
A method for treatment and amelioration of breast, cervical, ovarian, endometrial, squamous cells, prostate cancer and melanoma in a patient comprising targeting Id-1 or Id-2 gene expression with a delivery vehicle comprising a product which modulates Id-1 or Id-2 expression.
- Research Organization:
- Argonne National Laboratory (ANL), Argonne, IL (United States)
- Sponsoring Organization:
- USDOE
- DOE Contract Number:
- AC02-05CH11231
- Assignee:
- The Regents of the University of California (Oakland, CA)
- Patent Number(s):
- 8,846,629
- Application Number:
- 12/326,832
- OSTI ID:
- 1159928
- Country of Publication:
- United States
- Language:
- English
First Pass at Cancer Genome Reveals Complex Landscape
|
journal | September 2006 |
Targeting HER proteins in cancer therapy and the role of the non-target HER3
|
journal | July 2007 |
Similar Records
Id-1 gene and gene products as therapeutic targets for treatment of breast cancer and other types of carcinoma
Id-1 and Id-2 genes and products as markers of epithelial cancer
Id-1 and Id-2 genes and products as markers of epithelial cancer
Patent
·
2014
·
OSTI ID:1150642
Id-1 and Id-2 genes and products as markers of epithelial cancer
Patent
·
2008
·
OSTI ID:984513
Id-1 and Id-2 genes and products as markers of epithelial cancer
Patent
·
2011
·
OSTI ID:1029286